Vaccines: past, present and future

被引:350
作者
Plotkin, SA [1 ]
机构
[1] Univ Penn, Doylestown, PA 18901 USA
关键词
D O I
10.1038/nm1209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The vaccines developed over the first two hundred years since Jenner's lifetime have accomplished striking reductions of infection and disease wherever applied. Pasteur's early approaches to vaccine development, attenuation and inactivation, are even now the two poles of vaccine technology. Today, purification of microbial elements, genetic engineering and improved knowledge of immune protection allow direct creation of attenuated mutants, expression of vaccine proteins in live vectors, purification and even synthesis of microbial antigens, and induction of a variety of immune responses through manipulation of DNA, RNA, proteins and polysaccharides. Both noninfectious and infectious diseases are now within the realm of vaccinology. The profusion of new vaccines enables new populations to be targeted for vaccination, and requires the development of routes of administration additional to injection. With all this come new problems in the production, regulation and distribution of vaccines.
引用
收藏
页码:S5 / S11
页数:7
相关论文
共 87 条
[11]  
Calmette A, 1907, ANN I PASTEUR PARIS, V21, P401
[12]   Epidermal powder immunization of mice and monkeys with an influenza vaccine [J].
Chen, DX ;
Endres, R ;
Maa, YF ;
Kensil, CR ;
Whitaker-Dowling, P ;
Trichel, A ;
Youngner, JS ;
Payne, LG .
VACCINE, 2003, 21 (21-22) :2830-2836
[13]  
CLARK HF, 2004, VACCINES, P1327
[14]  
DECKER MD, 2004, VACCINES, P825, DOI DOI 10.1016/S0264-410X(02)00770-3
[15]   Gene expression microarrays: a 21st century tool for directed vaccine design [J].
Dhiman, N ;
Bonilla, R ;
O'Kane, D ;
Poland, GA .
VACCINE, 2001, 20 (1-2) :22-30
[16]   Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines [J].
Durbin, AP ;
Karron, RA .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (12) :1668-1677
[17]  
Excler JL, 1997, AIDS, V11, pS127
[18]   Development of StaphVAX™, a polysaccharide conjugate vaccine against S-aureus infection:: from the lab bench to phase III clinical trials [J].
Fattom, AI ;
Horwith, G ;
Fuller, S ;
Propst, M ;
Naso, R .
VACCINE, 2004, 22 (07) :880-887
[19]  
FENN EA, 2001, POX AM GREAT SMALLPO, V1
[20]   PROTECTION OF MICE AGAINST THE LYME-DISEASE AGENT BY IMMUNIZING WITH RECOMBINANT OSPA [J].
FIKRIG, E ;
BARTHOLD, SW ;
KANTOR, FS ;
FLAVELL, RA .
SCIENCE, 1990, 250 (4980) :553-556